Inflammatory profiling of patients with familial amyloid polyneuropathy

Abstract Background Familial amyloid polyneuropathy (FAP) or ATTRv (amyloid TTR variant) amyloidosis is a fatal hereditary disease characterized by the deposition of amyloid fibrils composed of transthyretin (TTR). The current diagnosis of ATTRv relies on genetic identification of TTR mutations and...

Full description

Bibliographic Details
Main Authors: Estefania P. Azevedo, Anderson B. Guimaraes-Costa, Christianne Bandeira-Melo, Leila Chimelli, Marcia Waddington-Cruz, Elvira M. Saraiva, Fernando L. Palhano, Debora Foguel
Format: Article
Language:English
Published: BMC 2019-06-01
Series:BMC Neurology
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12883-019-1369-4
_version_ 1819080267169529856
author Estefania P. Azevedo
Anderson B. Guimaraes-Costa
Christianne Bandeira-Melo
Leila Chimelli
Marcia Waddington-Cruz
Elvira M. Saraiva
Fernando L. Palhano
Debora Foguel
author_facet Estefania P. Azevedo
Anderson B. Guimaraes-Costa
Christianne Bandeira-Melo
Leila Chimelli
Marcia Waddington-Cruz
Elvira M. Saraiva
Fernando L. Palhano
Debora Foguel
author_sort Estefania P. Azevedo
collection DOAJ
description Abstract Background Familial amyloid polyneuropathy (FAP) or ATTRv (amyloid TTR variant) amyloidosis is a fatal hereditary disease characterized by the deposition of amyloid fibrils composed of transthyretin (TTR). The current diagnosis of ATTRv relies on genetic identification of TTR mutations and on Congo Red-positive amyloid deposits, which are absent in most ATTRv patients that are asymptomatic or early symptomatic, supporting the need for novel biomarkers to identify patients in earlier disease phases allowing disease control. Methods In an effort to search for new markers for ATTRv, our group searched for nine inflammation markers in ATTRv serum from a cohort of 28 Brazilian ATTRv patients. Results We found that the levels of six markers were increased (TNF-α, IL-1β, IL-8, IL-33, IFN-β and IL-10), one had decreased levels (IL-12) and two of them were unchanged (IL-6 and cortisol). Interestingly, asymptomatic patients already presented high levels of IL-33, IL-1β and IL-10, suggesting that inflammation may take place before fibril deposition. Conclusions Our findings shed light on a new, previously unidentified aspect of ATTRv, which might help define new criteria for disease management, as well as provide additional understanding of ATTRv aggressiveness.
first_indexed 2024-12-21T19:42:10Z
format Article
id doaj.art-a5ccb81299454e48be94330e84aa1ef4
institution Directory Open Access Journal
issn 1471-2377
language English
last_indexed 2024-12-21T19:42:10Z
publishDate 2019-06-01
publisher BMC
record_format Article
series BMC Neurology
spelling doaj.art-a5ccb81299454e48be94330e84aa1ef42022-12-21T18:52:26ZengBMCBMC Neurology1471-23772019-06-011911710.1186/s12883-019-1369-4Inflammatory profiling of patients with familial amyloid polyneuropathyEstefania P. Azevedo0Anderson B. Guimaraes-Costa1Christianne Bandeira-Melo2Leila Chimelli3Marcia Waddington-Cruz4Elvira M. Saraiva5Fernando L. Palhano6Debora Foguel7Instituto de Bioquímica Medica Leopoldo de Meis, Universidade Federal do Rio de JaneiroInstituto de Microbiologia Paulo de Goes, Universidade Federal do Rio de JaneiroInstituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de JaneiroServiço de Anatomia Patológica do Hospital Universitário Clementino Fraga Filho, Universidade Federal do Rio de JaneiroServiço de Neurologia do Hospital Universitário Clementino Fraga Filho, Universidade Federal do Rio de JaneiroInstituto de Microbiologia Paulo de Goes, Universidade Federal do Rio de JaneiroInstituto de Bioquímica Medica Leopoldo de Meis, Universidade Federal do Rio de JaneiroInstituto de Bioquímica Medica Leopoldo de Meis, Universidade Federal do Rio de JaneiroAbstract Background Familial amyloid polyneuropathy (FAP) or ATTRv (amyloid TTR variant) amyloidosis is a fatal hereditary disease characterized by the deposition of amyloid fibrils composed of transthyretin (TTR). The current diagnosis of ATTRv relies on genetic identification of TTR mutations and on Congo Red-positive amyloid deposits, which are absent in most ATTRv patients that are asymptomatic or early symptomatic, supporting the need for novel biomarkers to identify patients in earlier disease phases allowing disease control. Methods In an effort to search for new markers for ATTRv, our group searched for nine inflammation markers in ATTRv serum from a cohort of 28 Brazilian ATTRv patients. Results We found that the levels of six markers were increased (TNF-α, IL-1β, IL-8, IL-33, IFN-β and IL-10), one had decreased levels (IL-12) and two of them were unchanged (IL-6 and cortisol). Interestingly, asymptomatic patients already presented high levels of IL-33, IL-1β and IL-10, suggesting that inflammation may take place before fibril deposition. Conclusions Our findings shed light on a new, previously unidentified aspect of ATTRv, which might help define new criteria for disease management, as well as provide additional understanding of ATTRv aggressiveness.http://link.springer.com/article/10.1186/s12883-019-1369-4AmyloidTransthyretinBiomarkersCytokinesFamilial amyloid polyneuropathy
spellingShingle Estefania P. Azevedo
Anderson B. Guimaraes-Costa
Christianne Bandeira-Melo
Leila Chimelli
Marcia Waddington-Cruz
Elvira M. Saraiva
Fernando L. Palhano
Debora Foguel
Inflammatory profiling of patients with familial amyloid polyneuropathy
BMC Neurology
Amyloid
Transthyretin
Biomarkers
Cytokines
Familial amyloid polyneuropathy
title Inflammatory profiling of patients with familial amyloid polyneuropathy
title_full Inflammatory profiling of patients with familial amyloid polyneuropathy
title_fullStr Inflammatory profiling of patients with familial amyloid polyneuropathy
title_full_unstemmed Inflammatory profiling of patients with familial amyloid polyneuropathy
title_short Inflammatory profiling of patients with familial amyloid polyneuropathy
title_sort inflammatory profiling of patients with familial amyloid polyneuropathy
topic Amyloid
Transthyretin
Biomarkers
Cytokines
Familial amyloid polyneuropathy
url http://link.springer.com/article/10.1186/s12883-019-1369-4
work_keys_str_mv AT estefaniapazevedo inflammatoryprofilingofpatientswithfamilialamyloidpolyneuropathy
AT andersonbguimaraescosta inflammatoryprofilingofpatientswithfamilialamyloidpolyneuropathy
AT christiannebandeiramelo inflammatoryprofilingofpatientswithfamilialamyloidpolyneuropathy
AT leilachimelli inflammatoryprofilingofpatientswithfamilialamyloidpolyneuropathy
AT marciawaddingtoncruz inflammatoryprofilingofpatientswithfamilialamyloidpolyneuropathy
AT elviramsaraiva inflammatoryprofilingofpatientswithfamilialamyloidpolyneuropathy
AT fernandolpalhano inflammatoryprofilingofpatientswithfamilialamyloidpolyneuropathy
AT deborafoguel inflammatoryprofilingofpatientswithfamilialamyloidpolyneuropathy